Earnings Call · Q1 FY2024·2024-04-29

Q1 24EPS +50.75%·Rev n/aQ4 23EPS +8.00%·Rev n/aQ3 23EPS +37.40%·Rev n/aQ2 23EPS -35.11%·Rev n/a⚠ consensus missing

GeneDx Holdings Corp. WGS

Sabrina Dunbar — Commercial Chief of Staff

Katherine Stueland — President and Chief Executive Officer

We organized our entire team around 3 goals in the middle of last year — Unknown

Unknown — Unknown

Kevin Feeley — Chief Financial Officer

+55.2%1d on move date+56.8% vs SPY3d+77.3%5d+77.5%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more WGS calls or request research access.

More WGS calls Browse calls Request research access